Chylous ascites secondary to pancreatitis: management of an uncommon entity using parenteral nutrition and octreotide.
Malignancy, surgical trauma, cirrhosis and tuberculosis account for more than 95% of causes for chylous ascites. We report a case of persistent chylous ascites following acute pancreatitis that responded to parenteral nutrition and octreotide. A 50 year-old male was diagnosed with acute alcoholic pancreatitis after presenting with typical abdominal pain, and elevated amylase and lipase. The acute symptoms resolved within one week. Four weeks later he started developing increased abdominal girth. Examination revealed the presence of shifting dullness and paracentesis confirmed diagnosis of chylous ascites. Investigations for the common causes of chylous ascites were negative. Laparoscopy confirmed the presence of fat necrosis within mesenteric lymph nodes linking the chylous ascites to the episode of pancreatitis. The Chylous ascites was resistant to the usual medical therapy, but responded only to the combination of octreotide and total parenteral nutrition with complete resolution of ascites in 8 weeks. This case of chylous ascites secondary to pancreatitis represents an uncommon presentation with effective management resulting in a dramatic response.
Al-Ghamdi
Mohammed Y
MY
Division of Gastroenterology, Dalhousie University, Halifax, Nova Scotia, Canada.
Bedi
Anil
A
Reddy
S Bharati
SB
Tanton
Ronald T
RT
Peltekian
Kevork M
KM
D001706:Biopsy; D049448:Cholangiopancreatography, Magnetic Resonance; D002915:Chylous Ascites / Q000209:etiology* / Q000628:therapy; D003922:Diabetes Mellitus, Type 1 / Q000150:complications; D003937:Diagnosis, Differential; D005765:Gastrointestinal Agents / Q000627:therapeutic use*; D006801:Humans; D010535:Laparoscopy; D008297:Male; D008875:Middle Aged; D015282:Octreotide / Q000627:therapeutic use*; D019283:Pancreatitis, Acute Necrotizing / Q000150:complications* / Q000175:diagnosis; D010288:Parenteral Nutrition / Q000379:methods*
D005765:Gastrointestinal Agents; D015282:Octreotide